There is a new, potentially important player in the field of stem cell therapies for hair loss… and they’ve just made a deal for a ton of cash.
The new player is the Japanese stem cell development company Biomaster. It’s recently announced that its receiving an massive infusion of investment funding from the Chinese company, Shenzhen Beike Biotechnology.
You can read about Biomaster at…
Biomaster, Inc…
Biomaster specializes in research and commercialization of adipose-based stem cell therapies. Beike, along with two investment companies, has taken a significant share in Biomaster, secured a seat on the board, and is involved in the company’s strategic positioning in preparation for an eventual IPO.
“This deal has created a powerful partnership that plays to our companies’ respective advantages,” stated Shoko Murase, Ph.D, president of Biomaster. “Biomaster is uniquely positioned as the only facility allowed by law to offer stem-cell based therapy to the Japanese public. From a healthcare standpoint, our partnership with Beike will extend our services to patients at Beike’s affiliated clinical research institutes in China and worldwide.
The increased capital from this investment will enable Biomaster to advance its strategic aims of developing stem cell-based hair growth, spinal repair and organ regeneration therapies. Biomaster will benefit from Beike’s extensive clinical research network and broad access to the growing Chinese medical market.
I know everyone is very frustrated by the slow pace of research in this field… but this is another sign that a lot is going on behind the scenes. There are tremendous technical challenges that still must be solved. Research is continuing.
http://www.biomaster.jp/web_site/english/hair/index.html
http://www.beikebiotech.com/index.php?option=com_content&view=article&id=424:beike-biotechnology-invests-in-leading-japanese-regenerative-medicine-co-biomaster-inc&catid=10&Itemid=16
The new player is the Japanese stem cell development company Biomaster. It’s recently announced that its receiving an massive infusion of investment funding from the Chinese company, Shenzhen Beike Biotechnology.
You can read about Biomaster at…
Biomaster, Inc…
Biomaster specializes in research and commercialization of adipose-based stem cell therapies. Beike, along with two investment companies, has taken a significant share in Biomaster, secured a seat on the board, and is involved in the company’s strategic positioning in preparation for an eventual IPO.
“This deal has created a powerful partnership that plays to our companies’ respective advantages,” stated Shoko Murase, Ph.D, president of Biomaster. “Biomaster is uniquely positioned as the only facility allowed by law to offer stem-cell based therapy to the Japanese public. From a healthcare standpoint, our partnership with Beike will extend our services to patients at Beike’s affiliated clinical research institutes in China and worldwide.
The increased capital from this investment will enable Biomaster to advance its strategic aims of developing stem cell-based hair growth, spinal repair and organ regeneration therapies. Biomaster will benefit from Beike’s extensive clinical research network and broad access to the growing Chinese medical market.
I know everyone is very frustrated by the slow pace of research in this field… but this is another sign that a lot is going on behind the scenes. There are tremendous technical challenges that still must be solved. Research is continuing.
http://www.biomaster.jp/web_site/english/hair/index.html
http://www.beikebiotech.com/index.php?option=com_content&view=article&id=424:beike-biotechnology-invests-in-leading-japanese-regenerative-medicine-co-biomaster-inc&catid=10&Itemid=16